SK77494A3 - Piperidines and piperazines - Google Patents

Piperidines and piperazines Download PDF

Info

Publication number: SK77494A3
Authority: SK; Slovakia
Prior art keywords: formula; ethyl; piperidine; dimethoxyphenyl; compound
Prior art date: 1993-06-26

Application number

SK774-94A

Other languages

English (en)

Slovak (sk)

Inventor

Manfred Baumgarth

Inge Lues

Klaus-Otto Minck

Norbert Beier

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-26

Filing date

1994-06-27

Publication date

1995-07-11

1994-06-27 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1995-07-11 Publication of SK77494A3 publication Critical patent/SK77494A3/sk

Links

150000003053 piperidines Chemical class 0.000 title claims description 3
150000004885 piperazines Chemical class 0.000 title abstract description 3
150000003839 salts Chemical class 0.000 claims abstract description 22
125000004432 carbon atom Chemical group C* 0.000 claims abstract description 16
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims abstract description 10
125000000217 alkyl group Chemical group 0.000 claims abstract description 7
229910052794 bromium Inorganic materials 0.000 claims abstract description 7
229910052801 chlorine Inorganic materials 0.000 claims abstract description 7
229910052740 iodine Inorganic materials 0.000 claims abstract description 6
125000001589 carboacyl group Chemical group 0.000 claims abstract description 4
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims abstract description 3
125000003435 aroyl group Chemical group 0.000 claims abstract description 3
229910052731 fluorine Inorganic materials 0.000 claims abstract description 3
150000001875 compounds Chemical class 0.000 claims description 61
-1 4- (3,4-dimethoxyphenyl) -1-piperidinyl Chemical group 0.000 claims description 42
239000002253 acid Substances 0.000 claims description 20
238000000034 method Methods 0.000 claims description 13
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
230000009467 reduction Effects 0.000 claims description 10
238000004519 manufacturing process Methods 0.000 claims description 8
239000003814 drug Substances 0.000 claims description 7
238000002360 preparation method Methods 0.000 claims description 6
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
239000008194 pharmaceutical composition Substances 0.000 claims description 4
230000008569 process Effects 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
PNAWYAFVBUDGHL-UHFFFAOYSA-N 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(3,4-dimethoxyphenyl)piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3CC2)CC1 PNAWYAFVBUDGHL-UHFFFAOYSA-N 0.000 claims description 2
125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 2
ZJYZYEQNARPLOW-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(1,2,3,4-tetrahydronaphthalen-1-yl)ethyl]piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3CCC2)CC1 ZJYZYEQNARPLOW-UHFFFAOYSA-N 0.000 claims description 2
150000007514 bases Chemical class 0.000 claims description 2
239000002552 dosage form Substances 0.000 claims description 2
239000000546 pharmaceutical excipient Substances 0.000 claims description 2
125000004429 atom Chemical group 0.000 claims 1
239000007788 liquid Substances 0.000 claims 1
239000007787 solid Substances 0.000 claims 1
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 abstract description 2
230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
238000006243 chemical reaction Methods 0.000 description 17
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
239000001257 hydrogen Substances 0.000 description 15
229910052739 hydrogen Inorganic materials 0.000 description 15
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 11
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
239000000203 mixture Substances 0.000 description 9
239000000243 solution Substances 0.000 description 9
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 8
150000007513 acids Chemical class 0.000 description 7
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
239000004480 active ingredient Substances 0.000 description 6
239000002585 base Substances 0.000 description 6
150000002431 hydrogen Chemical class 0.000 description 6
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
239000002904 solvent Substances 0.000 description 6
PPVDQDZWCKBSER-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)piperidine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C1CCNCC1 PPVDQDZWCKBSER-UHFFFAOYSA-N 0.000 description 5
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 5
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 4
239000012280 lithium aluminium hydride Substances 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 4
239000011734 sodium Substances 0.000 description 4
239000007858 starting material Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
239000003826 tablet Substances 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
241000700198 Cavia Species 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000013543 active substance Substances 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
230000029936 alkylation Effects 0.000 description 3
238000005804 alkylation reaction Methods 0.000 description 3
150000001408 amides Chemical class 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
239000002775 capsule Substances 0.000 description 3
239000003638 chemical reducing agent Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000002425 crystallisation Methods 0.000 description 3
230000008025 crystallization Effects 0.000 description 3
239000012154 double-distilled water Substances 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
239000001530 fumaric acid Substances 0.000 description 3
229930195733 hydrocarbon Natural products 0.000 description 3
150000002430 hydrocarbons Chemical class 0.000 description 3
238000005984 hydrogenation reaction Methods 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
239000012442 inert solvent Substances 0.000 description 3
239000004310 lactic acid Substances 0.000 description 3
235000014655 lactic acid Nutrition 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000010626 work up procedure Methods 0.000 description 3
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 2
BUWPZNOVIHAWHW-UHFFFAOYSA-N 2,3-dihydro-1h-quinolin-4-one Chemical compound C1=CC=C2C(=O)CCNC2=C1 BUWPZNOVIHAWHW-UHFFFAOYSA-N 0.000 description 2
JLSDYCZGSJHQSV-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCNCC1 JLSDYCZGSJHQSV-UHFFFAOYSA-N 0.000 description 2
IWGKSLCQHLVACH-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-2,3,4,5-tetrahydro-1-benzoxepine-7-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC(=CC=C3OCCC2)C#N)CC1 IWGKSLCQHLVACH-UHFFFAOYSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical class [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
241000700159 Rattus Species 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
235000011054 acetic acid Nutrition 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
150000008044 alkali metal hydroxides Chemical class 0.000 description 2
150000001340 alkali metals Chemical class 0.000 description 2
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
239000003708 ampul Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
230000000747 cardiac effect Effects 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
238000006555 catalytic reaction Methods 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
150000004678 hydrides Chemical class 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
229910052742 iron Inorganic materials 0.000 description 2
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
239000008101 lactose Substances 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000001630 malic acid Substances 0.000 description 2
235000011090 malic acid Nutrition 0.000 description 2
229910052987 metal hydride Inorganic materials 0.000 description 2
150000004681 metal hydrides Chemical class 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000002674 ointment Substances 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
235000019271 petrolatum Nutrition 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
235000011007 phosphoric acid Nutrition 0.000 description 2
WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
229920001592 potato starch Polymers 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
239000000829 suppository Substances 0.000 description 2
239000011975 tartaric acid Substances 0.000 description 2
235000002906 tartaric acid Nutrition 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
229910052723 transition metal Inorganic materials 0.000 description 2
150000003624 transition metals Chemical class 0.000 description 2
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
OOKQCAIQHYSENI-UHFFFAOYSA-N 1,5-dichloropentan-3-ylbenzene Chemical compound ClCCC(CCCl)C1=CC=CC=C1 OOKQCAIQHYSENI-UHFFFAOYSA-N 0.000 description 1
JRSITDZRCRIDJQ-UHFFFAOYSA-N 1-(2-bromoethyl)-6-nitro-1,2,3,4-tetrahydronaphthalene Chemical compound BrCCC1CCCC2=CC([N+](=O)[O-])=CC=C21 JRSITDZRCRIDJQ-UHFFFAOYSA-N 0.000 description 1
QNQJGRVOECUROS-UHFFFAOYSA-N 1-[4-(3,4-dichlorophenyl)piperidin-1-yl]-2-(2,3-dihydro-1-benzofuran-3-yl)ethanone Chemical compound C1=C(Cl)C(Cl)=CC=C1C1CCN(C(=O)CC2C3=CC=CC=C3OC2)CC1 QNQJGRVOECUROS-UHFFFAOYSA-N 0.000 description 1
OLCWZRHKWGVIDI-UHFFFAOYSA-N 1-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]-2-(1,2,3,4-tetrahydroquinolin-4-yl)ethanone Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(C(=O)CC2C3=CC=CC=C3NCC2)CC1 OLCWZRHKWGVIDI-UHFFFAOYSA-N 0.000 description 1
LTXVRFCMXDASKK-UHFFFAOYSA-N 1-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]-2-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)ethanone Chemical compound C1CCC2=CC(OC)=CC=C2C1CC(=O)N(CC1)CCC1C1=CC=C(OC)C(OC)=C1 LTXVRFCMXDASKK-UHFFFAOYSA-N 0.000 description 1
FVHNTPZLPSHQLW-UHFFFAOYSA-N 1-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]-2-(7-methoxy-1,2,3,4-tetrahydroquinolin-4-yl)ethanone Chemical compound C1CNC2=CC(OC)=CC=C2C1CC(=O)N(CC1)CCC1C1=CC=C(OC)C(OC)=C1 FVHNTPZLPSHQLW-UHFFFAOYSA-N 0.000 description 1
SEWIUUBUSAWCLR-UHFFFAOYSA-N 1-[4-[2-(4-phenylpiperidin-1-yl)ethyl]-3,4-dihydro-2h-quinolin-1-yl]propan-1-one Chemical compound C12=CC=CC=C2N(C(=O)CC)CCC1CCN(CC1)CCC1C1=CC=CC=C1 SEWIUUBUSAWCLR-UHFFFAOYSA-N 0.000 description 1
CZKOSVIMSCDZRC-UHFFFAOYSA-N 1-[4-[2-[4-(1,3-benzodioxol-5-yl)piperidin-1-yl]ethyl]-3,4-dihydro-2h-quinolin-1-yl]ethanone Chemical compound C12=CC=CC=C2N(C(=O)C)CCC1CCN1CCC(C=2C=C3OCOC3=CC=2)CC1 CZKOSVIMSCDZRC-UHFFFAOYSA-N 0.000 description 1
LGXIIBHUZVRSRY-UHFFFAOYSA-N 1-[4-[2-[4-(1,3-benzodioxol-5-yl)piperidin-1-yl]ethyl]-3,4-dihydro-2h-quinolin-1-yl]propan-1-one Chemical compound C12=CC=CC=C2N(C(=O)CC)CCC1CCN1CCC(C=2C=C3OCOC3=CC=2)CC1 LGXIIBHUZVRSRY-UHFFFAOYSA-N 0.000 description 1
SAZPHCOWTAJPKH-UHFFFAOYSA-N 1-[4-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-3,4-dihydro-2h-quinolin-1-yl]ethanone Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3N(C(C)=O)CC2)CC1 SAZPHCOWTAJPKH-UHFFFAOYSA-N 0.000 description 1
RSTDERKXNVOGNM-UHFFFAOYSA-N 1-[4-[2-[4-(4-methoxyphenyl)piperidin-1-yl]ethyl]-3,4-dihydro-2h-quinolin-1-yl]ethanone Chemical compound C1=CC(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3N(C(C)=O)CC2)CC1 RSTDERKXNVOGNM-UHFFFAOYSA-N 0.000 description 1
DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
WYDCHFVIYWOUHU-UHFFFAOYSA-N 2-(6-amino-1,2,3,4-tetrahydronaphthalen-1-yl)-1-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)piperazin-1-yl]ethanone Chemical compound O1CCOC2=CC(N3CCN(CC3)C(=O)CC3C4=CC=C(C=C4CCC3)N)=CC=C21 WYDCHFVIYWOUHU-UHFFFAOYSA-N 0.000 description 1
OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
RAQCALJRWFADPY-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-1-[2-(2,3-dihydro-1-benzofuran-3-yl)ethyl]piperidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1CCN(CCC2C3=CC=CC=C3OC2)CC1 RAQCALJRWFADPY-UHFFFAOYSA-N 0.000 description 1
YYMRBZIDVSLGND-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(2,3,4,5-tetrahydro-1-benzoxepin-5-yl)ethyl]piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3OCCC2)CC1 YYMRBZIDVSLGND-UHFFFAOYSA-N 0.000 description 1
OMLYEQMSJZQCCY-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(5-methoxy-2,3-dihydro-1-benzofuran-3-yl)ethyl]piperidine Chemical compound C12=CC(OC)=CC=C2OCC1CCN(CC1)CCC1C1=CC=C(OC)C(OC)=C1 OMLYEQMSJZQCCY-UHFFFAOYSA-N 0.000 description 1
LHUUFZPNMAPMOC-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl]piperidine Chemical compound C1CCC2=CC(OC)=CC=C2C1CCN(CC1)CCC1C1=CC=C(OC)C(OC)=C1 LHUUFZPNMAPMOC-UHFFFAOYSA-N 0.000 description 1
RAZJFKYAHNNXCR-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(6-nitro-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl]piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=C(C=C3CCC2)[N+]([O-])=O)CC1 RAZJFKYAHNNXCR-UHFFFAOYSA-N 0.000 description 1
HJDXNOHDNKGBLP-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(6-nitro-2,3,4,5-tetrahydro-1-benzoxepin-5-yl)ethyl]piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=C(C=CC=C3OCCC2)[N+]([O-])=O)CC1 HJDXNOHDNKGBLP-UHFFFAOYSA-N 0.000 description 1
QZVDCVMAOTXQIY-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1-[2-(8-nitro-2,3,4,5-tetrahydro-1-benzoxepin-5-yl)ethyl]piperidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=C(C=C3OCCC2)[N+]([O-])=O)CC1 QZVDCVMAOTXQIY-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
JKMQCCVZNANBRF-UHFFFAOYSA-N 4-[2-(4-phenylpiperidin-1-yl)ethyl]-1-propan-2-yl-3,4-dihydro-2h-quinoline Chemical compound C12=CC=CC=C2N(C(C)C)CCC1CCN(CC1)CCC1C1=CC=CC=C1 JKMQCCVZNANBRF-UHFFFAOYSA-N 0.000 description 1
JLUNABQIUARAER-UHFFFAOYSA-N 4-[2-[4-(3,4-dichlorophenyl)piperidin-1-yl]ethyl]-1-methyl-3,4-dihydro-2h-quinoline Chemical compound C12=CC=CC=C2N(C)CCC1CCN(CC1)CCC1C1=CC=C(Cl)C(Cl)=C1 JLUNABQIUARAER-UHFFFAOYSA-N 0.000 description 1
RYWVNFXYVITQIV-UHFFFAOYSA-N 4-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-1,2,3,4-tetrahydroquinoline Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3NCC2)CC1 RYWVNFXYVITQIV-UHFFFAOYSA-N 0.000 description 1
KAAWFWMUBJCQHV-UHFFFAOYSA-N 4-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-1-ethyl-3,4-dihydro-2h-quinoline Chemical compound C12=CC=CC=C2N(CC)CCC1CCN(CC1)CCC1C1=CC=C(OC)C(OC)=C1 KAAWFWMUBJCQHV-UHFFFAOYSA-N 0.000 description 1
KIQCOCXCSDYCSV-UHFFFAOYSA-N 4-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-1-methyl-3,4-dihydro-2h-quinoline Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=CC=C3N(C)CC2)CC1 KIQCOCXCSDYCSV-UHFFFAOYSA-N 0.000 description 1
UVOGAEKABDPOML-UHFFFAOYSA-N 4-[2-[4-(4-nitrophenyl)piperidin-1-yl]ethyl]-1-propyl-3,4-dihydro-2h-quinoline Chemical compound C12=CC=CC=C2N(CCC)CCC1CCN(CC1)CCC1C1=CC=C([N+]([O-])=O)C=C1 UVOGAEKABDPOML-UHFFFAOYSA-N 0.000 description 1
ZDLQHQHEDHKWJO-UHFFFAOYSA-N 5-(2-bromoethyl)-2,3,4,5-tetrahydro-1-benzoxepin-6-amine Chemical compound O1CCCC(CCBr)C2=C1C=CC=C2N ZDLQHQHEDHKWJO-UHFFFAOYSA-N 0.000 description 1
QCFAHFGASIJVEN-UHFFFAOYSA-N 5-(2-bromoethyl)-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound BrCCC1CCCOC2=CC=CC=C12 QCFAHFGASIJVEN-UHFFFAOYSA-N 0.000 description 1
IFKVIYCKCJUUDF-UHFFFAOYSA-N 5-(2-bromoethyl)-2,3,4,5-tetrahydro-1-benzoxepine-6-carbonitrile Chemical compound BrCCC1CCCOC2=CC=CC(C#N)=C12 IFKVIYCKCJUUDF-UHFFFAOYSA-N 0.000 description 1
YUEISVORLUVPRH-UHFFFAOYSA-N 5-(2-bromoethyl)-2,3,4,5-tetrahydro-1-benzoxepine-7-carbonitrile Chemical compound BrCCC1CCCOC2=CC=C(C#N)C=C12 YUEISVORLUVPRH-UHFFFAOYSA-N 0.000 description 1
BGNWNDNFLWSQAY-UHFFFAOYSA-N 5-(2-bromoethyl)-6,7,8,9-tetrahydro-5h-benzo[7]annulene Chemical compound BrCCC1CCCCC2=CC=CC=C12 BGNWNDNFLWSQAY-UHFFFAOYSA-N 0.000 description 1
RNKKAPPBGBKVRT-UHFFFAOYSA-N 5-(2-bromoethyl)-6-chloro-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound O1CCCC(CCBr)C2=C1C=CC=C2Cl RNKKAPPBGBKVRT-UHFFFAOYSA-N 0.000 description 1
FWCUBPMEOJSPOH-UHFFFAOYSA-N 5-(2-bromoethyl)-6-methoxy-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound O1CCCC(CCBr)C2=C1C=CC=C2OC FWCUBPMEOJSPOH-UHFFFAOYSA-N 0.000 description 1
RAUDGPYLPBRWIK-UHFFFAOYSA-N 5-(2-bromoethyl)-6-nitro-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound O1CCCC(CCBr)C2=C1C=CC=C2[N+](=O)[O-] RAUDGPYLPBRWIK-UHFFFAOYSA-N 0.000 description 1
AAEZFYDWQUTYNI-UHFFFAOYSA-N 5-(2-bromoethyl)-7-chloro-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound O1CCCC(CCBr)C2=CC(Cl)=CC=C21 AAEZFYDWQUTYNI-UHFFFAOYSA-N 0.000 description 1
NJOMWEXCLBRLEK-UHFFFAOYSA-N 5-(2-bromoethyl)-8-nitro-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound BrCCC1CCCOC2=CC([N+](=O)[O-])=CC=C21 NJOMWEXCLBRLEK-UHFFFAOYSA-N 0.000 description 1
JDNRRJWVVKZMSG-UHFFFAOYSA-N 5-[2-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydronaphthalen-2-amine Chemical compound O1CCOC2=CC(N3CCN(CC3)CCC3C4=CC=C(C=C4CCC3)N)=CC=C21 JDNRRJWVVKZMSG-UHFFFAOYSA-N 0.000 description 1
PANGWCSQKLIOHT-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-2,3,4,5-tetrahydro-1-benzoxepin-6-amine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=C(N)C=CC=C3OCCC2)CC1 PANGWCSQKLIOHT-UHFFFAOYSA-N 0.000 description 1
UBUYUKAZJXUJRQ-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-2,3,4,5-tetrahydro-1-benzoxepin-7-ol Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC(O)=CC=C3OCCC2)CC1 UBUYUKAZJXUJRQ-UHFFFAOYSA-N 0.000 description 1
XWVIIXXDKJEORZ-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-2,3,4,5-tetrahydro-1-benzoxepine-6-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=C(C#N)C=CC=C3OCCC2)CC1 XWVIIXXDKJEORZ-UHFFFAOYSA-N 0.000 description 1
GQEFYUFRXCGWNT-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-2,3,4,5-tetrahydro-1-benzoxepine-8-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=C(C=C3OCCC2)C#N)CC1 GQEFYUFRXCGWNT-UHFFFAOYSA-N 0.000 description 1
AGFGICYVJWZQAW-UHFFFAOYSA-N 5-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydronaphthalen-2-amine Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC=C(N)C=C3CCC2)CC1 AGFGICYVJWZQAW-UHFFFAOYSA-N 0.000 description 1
PFJPTNWAKQBFAJ-UHFFFAOYSA-N 6-bromo-5-(2-bromoethyl)-2,3,4,5-tetrahydro-1-benzoxepine Chemical compound BrCCC1CCCOC2=CC=CC(Br)=C12 PFJPTNWAKQBFAJ-UHFFFAOYSA-N 0.000 description 1
JXIDWBFIIWMVEQ-UHFFFAOYSA-N 6-chloro-4-[2-[4-(3,4-dimethoxyphenyl)piperidin-1-yl]ethyl]-1,2,3,4-tetrahydroquinoline Chemical compound C1=C(OC)C(OC)=CC=C1C1CCN(CCC2C3=CC(Cl)=CC=C3NCC2)CC1 JXIDWBFIIWMVEQ-UHFFFAOYSA-N 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
238000005727 Friedel-Crafts reaction Methods 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
229910010082 LiAlH Inorganic materials 0.000 description 1
229910010084 LiAlH4 Inorganic materials 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000282887 Suidae Species 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
239000012346 acetyl chloride Substances 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
229910000272 alkali metal oxide Inorganic materials 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000003282 alkyl amino group Chemical group 0.000 description 1
150000001347 alkyl bromides Chemical class 0.000 description 1
150000001348 alkyl chlorides Chemical class 0.000 description 1
125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
125000004414 alkyl thio group Chemical group 0.000 description 1
FOJJCOHOLNJIHE-UHFFFAOYSA-N aluminum;azane Chemical compound N.[Al+3] FOJJCOHOLNJIHE-UHFFFAOYSA-N 0.000 description 1
238000010640 amide synthesis reaction Methods 0.000 description 1
150000001448 anilines Chemical group 0.000 description 1
NZLBHDRPUJLHCE-UHFFFAOYSA-N aprindine Chemical compound C1C2=CC=CC=C2CC1N(CCCN(CC)CC)C1=CC=CC=C1 NZLBHDRPUJLHCE-UHFFFAOYSA-N 0.000 description 1
229960004957 aprindine Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
TXFLGZOGNOOEFZ-UHFFFAOYSA-N bis(2-chloroethyl)amine Chemical compound ClCCNCCCl TXFLGZOGNOOEFZ-UHFFFAOYSA-N 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
230000031709 bromination Effects 0.000 description 1
238000005893 bromination reaction Methods 0.000 description 1
SIIVGPQREKVCOP-UHFFFAOYSA-N but-1-en-1-ol Chemical compound CCC=CO SIIVGPQREKVCOP-UHFFFAOYSA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229960004106 citric acid Drugs 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
125000004663 dialkyl amino group Chemical group 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
239000008298 dragée Substances 0.000 description 1
239000006196 drop Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
238000001640 fractional crystallisation Methods 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
229950006191 gluconic acid Drugs 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002837 heart atrium Anatomy 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000000297 inotrophic effect Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
125000004401 m-toluyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C(*)=O 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
YNLFEVAOQLXINF-UHFFFAOYSA-N methylsulfanylmethane;tribromoborane Chemical compound CSC.BrB(Br)Br YNLFEVAOQLXINF-UHFFFAOYSA-N 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
125000005440 p-toluyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C(*)=O)C([H])([H])[H] 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
210000003540 papillary muscle Anatomy 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
230000009090 positive inotropic effect Effects 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
238000010898 silica gel chromatography Methods 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000003530 tetrahydroquinolines Chemical class 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
125000001680 trimethoxyphenyl group Chemical group 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000008096 xylene Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)

SK774-94A 1993-06-26 1994-06-27 Piperidines and piperazines SK77494A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4321366A DE4321366A1 (de)	1993-06-26	1993-06-26	Piperidine und Piperazine

Publications (1)

Publication Number	Publication Date
SK77494A3 true SK77494A3 (en)	1995-07-11

Family

ID=6491352

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK774-94A SK77494A3 (en)	1993-06-26	1994-06-27	Piperidines and piperazines

Country Status (16)

Country	Link
US (1)	US5495022A (fr)
EP (1)	EP0634398A1 (fr)
JP (1)	JPH0725851A (fr)
KR (1)	KR950000691A (fr)
CN (1)	CN1102649A (fr)
AU (1)	AU6487294A (fr)
CA (1)	CA2126719A1 (fr)
CZ (1)	CZ155994A3 (fr)
DE (1)	DE4321366A1 (fr)
HU (1)	HUT70834A (fr)
NO (1)	NO942411L (fr)
PL (1)	PL303978A1 (fr)
RU (1)	RU94022271A (fr)
SK (1)	SK77494A3 (fr)
TW (1)	TW293818B (fr)
ZA (1)	ZA944573B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2188949A1 (fr) *	1994-04-28	1995-11-09	Janusz Jozef Kulagowski	Derives de benzofurane utilises comme antagonistes du recepteur d4
FR2734819B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
AU7261196A (en) *	1995-10-10	1997-04-30	Eli Lilly And Company	N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
GB9521347D0 (en) *	1995-10-18	1995-12-20	Merck Sharp & Dohme	Therapeutic agents
GB9912410D0 (en) *	1999-05-28	1999-07-28	Pfizer Ltd	Compounds useful in therapy
ES2806408T3 (es) *	2013-12-20	2021-02-17	Esteve Pharmaceuticals Sa	Compuestos piperidínicos con actividad multimodal contra el dolor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4302589A (en) *	1980-05-08	1981-11-24	American Cyanamid Company	Cis-mono and disubstituted-2-methyl-3-[(piperazinyl) and (piperidino)ethyl]indolines, intermediates for their preparation and methods of preparation
FR2618437B1 (fr) *	1987-07-23	1989-11-17	Rhone Poulenc Sante	Nouveaux derives du benzopyranne, leur preparation et les medicaments qui les contiennent
FR2670491B1 (fr) *	1990-12-14	1993-02-05	Adir	Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.

1993
- 1993-06-26 DE DE4321366A patent/DE4321366A1/de not_active Withdrawn
1994
- 1994-04-24 RU RU94022271/04A patent/RU94022271A/ru unknown
- 1994-06-14 EP EP94109058A patent/EP0634398A1/fr not_active Withdrawn
- 1994-06-20 JP JP6136940A patent/JPH0725851A/ja active Pending
- 1994-06-22 AU AU64872/94A patent/AU6487294A/en not_active Abandoned
- 1994-06-24 US US08/264,872 patent/US5495022A/en not_active Expired - Fee Related
- 1994-06-24 PL PL94303978A patent/PL303978A1/xx unknown
- 1994-06-24 HU HU9401914A patent/HUT70834A/hu unknown
- 1994-06-24 CZ CZ941559A patent/CZ155994A3/cs unknown
- 1994-06-24 CA CA002126719A patent/CA2126719A1/fr not_active Abandoned
- 1994-06-24 TW TW083105752A patent/TW293818B/zh active
- 1994-06-24 NO NO942411A patent/NO942411L/no unknown
- 1994-06-24 CN CN94106806A patent/CN1102649A/zh active Pending
- 1994-06-24 ZA ZA944573A patent/ZA944573B/xx unknown
- 1994-06-25 KR KR1019940014712A patent/KR950000691A/ko not_active Withdrawn
- 1994-06-27 SK SK774-94A patent/SK77494A3/sk unknown

Also Published As

Publication number	Publication date
HU9401914D0 (en)	1994-09-28
ZA944573B (en)	1995-02-14
PL303978A1 (en)	1995-01-09
CN1102649A (zh)	1995-05-17
JPH0725851A (ja)	1995-01-27
HUT70834A (en)	1995-11-28
CA2126719A1 (fr)	1994-12-27
US5495022A (en)	1996-02-27
NO942411D0 (fr)	1994-06-24
EP0634398A1 (fr)	1995-01-18
RU94022271A (ru)	1996-04-20
TW293818B (fr)	1996-12-21
NO942411L (no)	1994-12-27
KR950000691A (ko)	1995-01-03
CZ155994A3 (en)	1995-10-18
DE4321366A1 (de)	1995-01-05
AU6487294A (en)	1995-01-05

Publication	Publication Date	Title
CA1264324A (fr)	1990-01-09	4-phenylmethoxy-1-(substitution) phenylbutylpiperidines; methode de preparation et compositions pharmaceutiques a base de ces composes
US3813384A (en)	1974-05-28	Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
EP0040639B1 (fr)	1984-05-30	Derives isoxazoles
US4430343A (en)	1984-02-07	Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
HU214578B (hu)	1998-04-28	Eljárás aril-acetamidok, valamint hatóanyagként ezen vegyületeket tartalmazó gyógyászati készítmények előállítására
US4590273A (en)	1986-05-20	Isoquinoline compounds
US4234584A (en)	1980-11-18	Substituted phenylpiperazine derivatives
US5852019A (en)	1998-12-22	Pyrimidinylpyrazole derivatives
US4414216A (en)	1983-11-08	Tetrahydrofuran compounds and analogs thereof
US4806547A (en)	1989-02-21	Isoquinoline derivatives, analgesic compounds thereof and method of treating pain
US5569659A (en)	1996-10-29	4-arylpiperazines and 4-arylpiperidines
WO2004054972A1 (fr)	2004-07-01	Composes de n-(indolethyl-)cycloamine
EP0399414B1 (fr)	1994-09-21	Dérivé de pipéridine, procédé de sa préparation et composition pharmaceutique le contenant
EP0191867B1 (fr)	1991-10-16	Composes tricycliques ou tetracycliques, procede de preparation et composition medicinale les contenant
US4322418A (en)	1982-03-30	Substituted 1-(α-aminocarbonyl-benzyl)-3,4-dihydro-isoquinolines, compositions and use
SK85294A3 (en)	1995-03-08	4-axyloxy- and 4-arylthiopiperidine derivatives
US3840529A (en)	1974-10-08	1-(1-(3-substituted-1-propenyl)-4-piperidyl)-2-oxobenzimidazolines
US5495022A (en)	1996-02-27	Piperidines and piperazines
JPH07188162A (ja)	1995-07-25	サイクリックアミン誘導体
US4089861A (en)	1978-05-16	(+)-(S)-Enantiomer of 3-{2-[4-(8-fluoro-10,11-dihydro-2-methyl-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl}-2-oxazolidinone
CA2220140C (fr)	2008-02-12	Derives de (2-morpholinylmethyl)benzamide
US5254561A (en)	1993-10-19	Tricyclic antipsychotic agents
HU195652B (en)	1988-06-28	Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active ingredients
US5234924A (en)	1993-08-10	Benzothiazine and benzothiazole compounds useful as analgesics
IE64792B1 (en)	1995-09-06	New bis (aryl) alkene derivatives processes for preparing them and pharmaceutical compositions containing them